Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ALOSTRA: Discontinuation of alendronate in rheumatoid arthritis patients with osteopenia-range bone density
2015-003638-28Phase 2Completed
- Sponsor
- Aarhus University Hospital
- Start
- Aug 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2 trial of alendronate in rheumatoid arthritis (RA) and osteoporosis (2 arms), sponsored by Aarhus University Hospital. Primary endpoints: Change in serum CTX at 6 months and Change in serum P1NP at 6 months. Started Aug 2015; status: completed.
02
Drugs
alendronate
03
Conditions
rheumatoid arthritis (RA)osteoporosis
Beyond the preview
Go deeper on 2015-003638-28.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2015-003638-28.